Please login to the form below

Not currently logged in


This page shows the latest Cyramza news and features for those working in and with pharma, biotech and healthcare.

Lilly scores FDA okay for Cyramza in liver cancer

Lilly scores FDA okay for Cyramza in liver cancer

Approved as second line treatment after Bayer’s Nexavar. Eli Lilly has added a fifth indication for its cancer drug Cyramza, getting an FDA approval for hepatocellular carcinoma (HCC) that expresses ... Lilly has also filed for approval of Cyramza in

Latest news

More from news
Approximately 10 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...